Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Medical Specialties (740)
- Neurology (428)
- Medical Sciences (410)
- Life Sciences (305)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (271)
-
- Neurosciences (194)
- Pathological Conditions, Signs and Symptoms (152)
- Neuroscience and Neurobiology (149)
- Chemicals and Drugs (128)
- Internal Medicine (116)
- Medical Neurobiology (115)
- Diagnosis (108)
- Therapeutics (104)
- Pharmacy and Pharmaceutical Sciences (102)
- Anatomy (98)
- Cardiovascular Diseases (97)
- Rehabilitation and Therapy (90)
- Public Health (88)
- Mental and Social Health (86)
- Psychiatry and Psychology (82)
- Social and Behavioral Sciences (80)
- Molecular and Cellular Neuroscience (76)
- Nervous System (75)
- Immune System Diseases (60)
- Cell and Developmental Biology (56)
- Pediatrics (56)
- Other Pharmacy and Pharmaceutical Sciences (54)
- Institution
-
- University of San Diego (311)
- HCA Healthcare (211)
- Rowan University (149)
- Thomas Jefferson University (111)
- Chapman University (108)
-
- The Texas Medical Center Library (73)
- Aga Khan University (66)
- Philadelphia College of Osteopathic Medicine (56)
- LSU Health New Orleans (55)
- University of Kentucky (48)
- Touro College and University System (39)
- Himmelfarb Health Sciences Library, The George Washington University (35)
- University of Texas Rio Grande Valley (24)
- Virginia Commonwealth University (23)
- University of Tennessee Health Science Center (21)
- City University of New York (CUNY) (19)
- Liberty University (17)
- Marshall University (15)
- Old Dominion University (15)
- Wayne State University (14)
- Children's Mercy Kansas City (13)
- University of Nebraska Medical Center (13)
- Edith Cowan University (12)
- University of Nevada, Las Vegas (12)
- West Virginia University (11)
- Baptist Health South Florida (10)
- Ohio Northern University (10)
- Portland State University (10)
- Roseman University of Health Sciences (10)
- University of Connecticut (10)
- Keyword
-
- Huntington's Disease (313)
- Humans (93)
- Stroke (81)
- Female (60)
- Male (59)
-
- Alzheimer’s disease (51)
- Middle Aged (40)
- Adult (39)
- Neurodegeneration (39)
- Dementia (37)
- Epilepsy (36)
- Parkinson's disease (36)
- Multiple sclerosis (33)
- Alzheimer's disease (31)
- Neuroinflammation (29)
- Aged (27)
- Multiple Sclerosis (27)
- Alzheimer's Disease (25)
- Animals (25)
- Biomarkers (25)
- Inflammation (23)
- Parkinson's Disease (23)
- Alzheimer Disease (22)
- Parkinson’s disease (22)
- Brain (21)
- COVID-19 (21)
- Microglia (20)
- Cognition (19)
- Mice (19)
- Parkinson Disease (19)
- Publication Year
- Publication
-
- At Risk for Huntington's Disease (309)
- Rowan-Virtua Research Day (115)
- Pharmacy Faculty Articles and Research (51)
- School of Medicine Faculty Publications (43)
- PCOM Physician Assistant Studies Student Scholarship (37)
-
- Department of Medicine (27)
- Physical Therapy Faculty Articles and Research (26)
- Department of Neurology Faculty Papers (25)
- Faculty, Staff and Student Publications (25)
- Rowan-Virtua School of Osteopathic Medicine Departmental Research (24)
- Theses and Dissertations (24)
- Dissertations and Theses (Open Access) (23)
- Faculty, Staff and Students Publications (23)
- The Science Journal of the Lander College of Arts and Sciences (21)
- Theses and Dissertations (ETD) (19)
- South Atlantic Division GME Research Days 2026 (17)
- Senior Honors Theses (14)
- East Florida Division GME Research Day 2023 (13)
- Neurology Faculty Publications (13)
- South Atlantic Division GME Research Day 2024 (13)
- Continental and Mountain Divisions GME Resarch Day 2026 (12)
- Research Symposium (12)
- Department of Neurosurgery Faculty Papers (11)
- Graduate Theses, Dissertations, and Problem Reports (ETD) (11)
- Theses & Dissertations (11)
- All Publications (10)
- Annual Research Symposium (10)
- Biology, Chemistry, and Environmental Sciences Faculty Articles and Research (10)
- Dissertations, Theses, and Capstone Projects (10)
- Gulf Coast Division GME Research Day 2026 (10)
- Publication Type
- File Type
Articles 931 - 960 of 1882
Full-Text Articles in Nervous System Diseases
Vitamin B12 Deficiency Does Not Stimulate Amyloid-Beta Toxicity In A Ceanorhabditis Elegans Model Of Alzheimer’S Disease, Opeyemi F. Showemimo
Vitamin B12 Deficiency Does Not Stimulate Amyloid-Beta Toxicity In A Ceanorhabditis Elegans Model Of Alzheimer’S Disease, Opeyemi F. Showemimo
Electronic Theses and Dissertations
Alzheimer’s disease (AD) is symptomized by amyloid-beta plaques in the brain and accounts for more than 65 percent of dementia cases. Vitamin B12 (cobalamin) deficiency can result in similar cognitive impairment and roughly 15% of the elderly are vitamin B12 deficient. Vitamin B12 deficiency results in the accumulation of toxic methylmalonic acid and homocysteine. Hyperhomocysteinemia is a strong risk factor for AD. To test if vitamin B12 deficiency stimulates amyloid-beta toxicity, Caenorhabditis elegans expressing amyloid-beta in muscle were fed either vitamin B12-deficient OP50-1 or vitamin B12-rich HT115(DE3) E. coli bacteria. Increased amyloid-beta toxicity was found in worms fed the …
Headache-Related Disability Among Individuals With And Without Migraine Aura, Delora Denney
Headache-Related Disability Among Individuals With And Without Migraine Aura, Delora Denney
Honors Theses
Migraine is a neurological disease marked by recurrent headache and migraine attacks. Migraine is one of the most common diseases in the world, and as a result of high prevalence and symptoms, migraine is also quite disabling. One-third of people who have migraine experience aura, and these individuals have a greater risk for stroke, psychiatric comorbidities, and suicide attempts. The present study aimed to evaluate if there was a difference in headache-related disability between those who have migraine with and without aura, and any headache or psychiatric factors that may account for observed difference in disability.
The present study is …
Investigating Diffusion Tensor Imaging Correlates Of Cognitive Impairment In Idiopathic Normal Pressure Hydrocephalus And Alzheimer's Disease, Omar Hasan, Omar Hasan
Investigating Diffusion Tensor Imaging Correlates Of Cognitive Impairment In Idiopathic Normal Pressure Hydrocephalus And Alzheimer's Disease, Omar Hasan, Omar Hasan
Dissertations and Theses (Open Access)
Modest expansion of the human brain cerebrospinal fluid (CSF)-filled ventricles is normal with aging, and because of this, it can be difficult for physicians to accurately diagnose and treat enlarged ventricles (ventriculomegaly), called hydrocephalus1 (fluid or water in the brain) Ventriculomegaly occurs due to an obstruction (such as a blood clot or tumor), or a change in CSF absorption2. Primary hydrocephalus, also called idiopathic normal pressure hydrocephalus (iNPH), is non-obstructive and may be comorbid with other neurodegenerative diseases such as Alzheimer’s disease (AD) or frontotemporal dementia (FTD). Clinically, it can be difficult to tell whether the pathophysiological …
Criterion Validity Of The Ohio State University Traumatic Brain Injury Identification Method In A Criminal Justice Sample, Sarah M. Monaghan
Criterion Validity Of The Ohio State University Traumatic Brain Injury Identification Method In A Criminal Justice Sample, Sarah M. Monaghan
Student Theses
The purpose of the current study was to determine the clinical utility of the Ohio State University Traumatic Brain Injury Identification Method (OSU-TBI-ID) in a criminal justice sample, by evaluating the criterion-related validity of this instrument. It was hypothesized that this tool could differentiate between incarcerated individuals with or without a history of Traumatic Brain Injury (TBI) on measures evaluating important TBI-related sequalae. The sample consisted of 95 incarcerated men detained at a private correctional facility in a Mid-Atlantic state. Measures used in this study to evaluate executive functioning difficulties, psychiatric difficulties, substance use problems, institutional misconduct and recidivism were …
Development And Validation Of A Predictive Model For Childhood Mortality After A Traumatic Brain Injury: Analysis Of The National Trauma Data Bank, Jooby Joy, Axel Moreira, Kevin Chorath, Karthik Rajasekaran, Alvaro Moreira
Development And Validation Of A Predictive Model For Childhood Mortality After A Traumatic Brain Injury: Analysis Of The National Trauma Data Bank, Jooby Joy, Axel Moreira, Kevin Chorath, Karthik Rajasekaran, Alvaro Moreira
School of Medicine Publications
Introduction: Traumatic brain injury (TBI) is a significant cause of morbidity and mortality in children. While most TBI-related admissions are mild, identifying early predictors of poor outcome may assist clinicians with timely medical decisions and effective triage utilization.
Objective: We sought to develop and validate a clinical tool for predicting in-hospital death in children after a traumatic brain injury.
Methods: Data was collected for children (≤18 years) from the National Trauma Data Bank between the years of 2007 to 2015. We included children who sustained any TBI, defined as: (i) open and closed skull fractures, (ii) cerebellar, cortical, or brain …
Roche Confirms Tominersen As Ineffective, While Triplet Provides Key Details For Trial Of Drug To Slow Major Driver Of Huntington's Disease, Kenneth P. Serbin
Roche Confirms Tominersen As Ineffective, While Triplet Provides Key Details For Trial Of Drug To Slow Major Driver Of Huntington's Disease, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
With Proof-Hd In The Lead, The Huntington’S Disease Drug Pipeline Is Still 'Full Of Hope' (Coping With Disappointing Clinical Trial Results – Part Ii), Kenneth P. Serbin
With Proof-Hd In The Lead, The Huntington’S Disease Drug Pipeline Is Still 'Full Of Hope' (Coping With Disappointing Clinical Trial Results – Part Ii), Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Characterizing Subtypes And Neural Correlates Of Receptive Aprosodia In Acute Right Hemisphere Stroke, Shannon M. Sheppard, Erin L. Meier, Alexandra Zezinka Durfee, Alex Walker, Jennifer Shea, Argye E. Hillis
Characterizing Subtypes And Neural Correlates Of Receptive Aprosodia In Acute Right Hemisphere Stroke, Shannon M. Sheppard, Erin L. Meier, Alexandra Zezinka Durfee, Alex Walker, Jennifer Shea, Argye E. Hillis
Communication Sciences and Disorders Faculty Articles and Research
Introduction: Speakers naturally produce prosodic variations depending on their emotional state. Receptive prosody has several processing stages. We aimed to conduct lesion-symptom mapping to determine whether damage (core infarct or hypoperfusion) to specific brain areas was associated with receptive aprosodia or with impairment at different processing stages in individuals with acute right hemisphere stroke. We also aimed to determine whether different subtypes of receptive aprosodia exist that are characterized by distinctive behavioral performance patterns.
Methods: Twenty patients with receptive aprosodia following right hemisphere ischemic stroke were enrolled within five days of stroke; clinical imaging was acquired. Participants completed …
C25: The “Spot Sign”: A Predictor Of Hematoma Expansion, Mckenzie Merritt
C25: The “Spot Sign”: A Predictor Of Hematoma Expansion, Mckenzie Merritt
Annual Research Symposium
No abstract provided.
Management Of Paediatric Intracranial Ependymoma, Syeda Kubra Kishwar Jafri, Saqib Kamran Bakhshi, Muhammad Shahzad Shamim
Management Of Paediatric Intracranial Ependymoma, Syeda Kubra Kishwar Jafri, Saqib Kamran Bakhshi, Muhammad Shahzad Shamim
Section of Neurosurgery
Intracranial ependymoma are relatively common paediatric brain tumours, but their eloquent location and high recurrence rate pose a significant challenge. Gross total resection or maximum safe resection followed by adjuvant radiotherapy are currently the standard recommended treatment, although there is still nearly 50% recurrence risk at 5 years. Chemotherapy has shown some promising results after recent advances in molecular understanding of ependymomas, but needs further evaluation before it could be added to the treatment regime.
Tranexamic Acid To Reduce Head Injury Death In People With Traumatic Brain Injury: The Crash-3 International Rct, Ian Roberts, Haleema Shakur-Still, Amy Aeron-Thoma, Danielle Beaumont, Antonio Belli, Amy Brenner, Madeleine Cargill, Rizwana Chaudhri, Nicolas Douglas, Rashid Jooma
Tranexamic Acid To Reduce Head Injury Death In People With Traumatic Brain Injury: The Crash-3 International Rct, Ian Roberts, Haleema Shakur-Still, Amy Aeron-Thoma, Danielle Beaumont, Antonio Belli, Amy Brenner, Madeleine Cargill, Rizwana Chaudhri, Nicolas Douglas, Rashid Jooma
Section of Neurosurgery
Background: Tranexamic acid safely reduces mortality in traumatic extracranial bleeding. Intracranial bleeding is common after traumatic brain injury and can cause brain herniation and death. We assessed the effects of tranexamic acid in traumatic brain injury patients.
Objective: To assess the effects of tranexamic acid on death, disability and vascular occlusive events in traumatic brain injury patients. We also assessed cost-effectiveness.
Design: Randomised trial and economic evaluation. Patients were assigned by selecting a numbered treatment pack from a box containing eight packs that were identical apart from the pack number. Patients, caregivers and those assessing outcomes were masked to allocation. …
Overcoming A ‘Heartbreaking’ Moment For The Huntington's Disease Cause (Coping With Disappointing Clinical Trial Results – Part I), Kenneth P. Serbin
Overcoming A ‘Heartbreaking’ Moment For The Huntington's Disease Cause (Coping With Disappointing Clinical Trial Results – Part I), Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Huntington's Disease: A Timeline, Brian Kerlin, Brandon Polimeni, Michaelangelo Ortega
Huntington's Disease: A Timeline, Brian Kerlin, Brandon Polimeni, Michaelangelo Ortega
Undergraduate Research Symposium Posters
The purpose of this investigation is to examine the discovery, treatment, social impact, and current research for Huntington’s disease (HD) to provide a foundation to analyze future research towards a cure. Huntington’s disease was first comprehensively described in 1872 by George Huntington. HD is an autosomal-dominant, neurodegenerative disorder that affects approximately 2.7 per 100,000. Individuals with HD present with involuntary muscle movement, cognitive decline, and personality alterations arising at a mean age of 35 years. Symptoms are subtle at first, but as the disease progresses over 15-20 years, the individual’s ability to talk diminishes and their mental abilities decline into …
Autism: A Deep Insight, Hemaila Tariq, Muhammad Yusuf Hafiz
Autism: A Deep Insight, Hemaila Tariq, Muhammad Yusuf Hafiz
Medical College Documents
No abstract provided.
Ion Channel Candidates Mediating Orexin Neuropeptide Actions On Brainstem Serotonergic Neurons, Saqlain Javed
Ion Channel Candidates Mediating Orexin Neuropeptide Actions On Brainstem Serotonergic Neurons, Saqlain Javed
NYMC Student Theses and Dissertations
A loss of neurons that synthesize the neuropeptide orexin produces the sleep disorder narcolepsy with cataplexy in humans and other animals. How symptoms of this disorder arise is not well understood, but selectively restoring orexin actions at 5-HT DR neurons rescues key symptoms (cataplexy), suggesting normal orexin signaling is important at these neurons. To better understand how orexin acts on these neurons, our lab identified a set of novel orexin actions that appear mediated by unidentified cation- permeable ion channels. To narrow down the list of possible channels, we used a bioinformatics approach to compare published gene expression profiles of …
Serious Adverse Events And 30-Day Hospital Readmission Rate Following Elective Total Knee Arthroplasty: A Systematic Review And Meta-Analysis., Costas Papakostidis, Peter V Giannoudis, J. Tracy Watson, Robert Zura, R. Grant Steen
Serious Adverse Events And 30-Day Hospital Readmission Rate Following Elective Total Knee Arthroplasty: A Systematic Review And Meta-Analysis., Costas Papakostidis, Peter V Giannoudis, J. Tracy Watson, Robert Zura, R. Grant Steen
School of Medicine Faculty Publications
Background: Elective total knee arthroplasty (TKA) is a common surgery which has evolved rapidly. However, there are no recent large systematic reviews of serious adverse event (SAE) rate and 30-day readmission rate (30-dRR) or an indication of whether surgical methods have improved. Methods: To obtain a pooled estimate of SAE rate and 30-dRR following TKA, we searched Medline, Web of Science, Cochrane Library, and Google Scholar databases. Data were extracted by two authors following PRISMA guidelines. Eligibility criteria were defined prior to a comprehensive search. Studies were eligible if they were published in 2007 or later, described sequelae of TKA …
Allogeneic Bone Marrow–Derived Mesenchymal Stem Cell Safety In Idiopathic Parkinson’S Disease, Timothy M. Ellmore
Allogeneic Bone Marrow–Derived Mesenchymal Stem Cell Safety In Idiopathic Parkinson’S Disease, Timothy M. Ellmore
Publications and Research
Background Neuroinflammation plays a key role in PD pathogenesis, and allogeneic bone marrow–derived mesenchymal stem cells can be used as an immunomodulatory therapy. Objective The objective of this study was to prove the safety and tolerability of intravenous allogeneic bone marrow–derived mesenchymal stem cells in PD patients. Methods This was a 12‐month single‐center open‐label dose‐escalation phase 1 study of 20 subjects with mild/moderate PD assigned to a single intravenous infusion of 1 of 4 doses: 1, 3, 6, or 10 × 106 allogeneic bone marrow–derived mesenchymal stem cells/kg, evaluated 3, 12, 24, and 52 weeks postinfusion. Primary outcome safety measures …
Tough News For Huntington’S, Other Neurological Disease Patients: Roche Halts Dosing In Historic Clinical Trials On Signs Of Inefficacy, Kenneth P. Serbin
Tough News For Huntington’S, Other Neurological Disease Patients: Roche Halts Dosing In Historic Clinical Trials On Signs Of Inefficacy, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Intepirdine As Adjunctive Therapy To Donepezil For Mild-To-Moderate Alzheimer’S Disease: A Randomized, Placebo-Controlled, Phase 3 Clinical Trial (Mindset), Frederick M. Lang, Yi Mo, Marwan Sabbagh, Paul Solomon, Merce Boada, Roy W. Jones, Giovanni B. Frisoni, Timo Grimmer, Bruno Dubois, Mark Harnett, Sarah R. Friedhoff, Shari Coslett, Jeffrey L. Cummings
Intepirdine As Adjunctive Therapy To Donepezil For Mild-To-Moderate Alzheimer’S Disease: A Randomized, Placebo-Controlled, Phase 3 Clinical Trial (Mindset), Frederick M. Lang, Yi Mo, Marwan Sabbagh, Paul Solomon, Merce Boada, Roy W. Jones, Giovanni B. Frisoni, Timo Grimmer, Bruno Dubois, Mark Harnett, Sarah R. Friedhoff, Shari Coslett, Jeffrey L. Cummings
Brain Health Faculty Research
Introduction: A previous phase 2b study supported the use of the 5-HT6 receptor antagonist intepirdine as adjunctive therapy to donepezil for Alzheimer's disease (AD) dementia. A phase 3 study, MINDSET, was performed to test this hypothesis. Methods: MINDSET was a global, double-blind, randomized, placebo-controlled trial in 1315 mild-to-moderate AD dementia patients on stable donepezil. Patients received 35 mg/day intepirdine or placebo for 24 weeks. The co-primary endpoints were change from baseline to week 24 on the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) and Alzheimer's Disease Cooperative Study-Activities of Daily Living (ADCS-ADL). Results: There were no statistically significant differences between intepirdine …
Blog Article No. 300: Who Exactly Is Gene Veritas?, Kenneth P. Serbin
Blog Article No. 300: Who Exactly Is Gene Veritas?, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Management Of Intracranial Haemangiopericytomas, Noman Ahmad, Saqib Kamran Bakhshi, Muhammad Shahzad Shamim
Management Of Intracranial Haemangiopericytomas, Noman Ahmad, Saqib Kamran Bakhshi, Muhammad Shahzad Shamim
Section of Neurosurgery
Haemangiopericytomas are rare tumours, commonly mistaken as meningiomas on radiology. These tumours are considered malignant and treatment involves aggressive surgery, followed by adjuvant radiation therapy, and close radiological and clinical follow ups. Herein the authors have reviewed the recent literature on the management of these tumours.
Occupational Therapy’S Role In Addressing Sexuality And Intimacy For Individuals With Progressive Neuromuscular Disorders, Lindsay N. Richards
Occupational Therapy’S Role In Addressing Sexuality And Intimacy For Individuals With Progressive Neuromuscular Disorders, Lindsay N. Richards
Student Capstone Papers
Individuals with progressive neuromuscular disorders (PND); specifically, Parkinson’s disease (PD), Multiple Sclerosis (MS), Huntington’s Disease (HD), and Amyotrophic Lateral Sclerosis (ALS) often face physical, psychological, and social challenges related to sex and intimacy. Occupational therapy (OT) practitioners are experts in activity analysis and are equipped with unique knowledge of performance skills and client factors to address deficits in occupational performance.
Though there is literature presenting the effects of PND on sexual occupations, a gap exists as it relates to qualitative data from the perspective of the individual and their partners. A mixed-methods survey was conducted examining the lived experience of …
Getting The Covid-19 Vaccine And A New Exercise Bike To Keep Stable In The Fight Against Huntington's Disease, Kenneth P. Serbin
Getting The Covid-19 Vaccine And A New Exercise Bike To Keep Stable In The Fight Against Huntington's Disease, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
My Arduous, Lucky, And Enlightening Journey Since My Mother's Death From Huntington's Disease 15 Years Ago, Kenneth P. Serbin
My Arduous, Lucky, And Enlightening Journey Since My Mother's Death From Huntington's Disease 15 Years Ago, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
The Mechanism Of Β-N-Methylamino-L-Alanine Inhibition Of Trna Aminoacylation And Its Impact On Misincorporation, Nien-Ching Han, Tammy J. Bullwinkle, Kaeli F. Loeb, Kym F. Faull, Kyle Mohler, Jesse Rinehart, Michael Ibba
The Mechanism Of Β-N-Methylamino-L-Alanine Inhibition Of Trna Aminoacylation And Its Impact On Misincorporation, Nien-Ching Han, Tammy J. Bullwinkle, Kaeli F. Loeb, Kym F. Faull, Kyle Mohler, Jesse Rinehart, Michael Ibba
Biology, Chemistry, and Environmental Sciences Faculty Articles and Research
β-N-methylamino-l-alanine (BMAA) is a nonproteinogenic amino acid that has been associated with neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and Alzheimer's disease (AD). BMAA has been found in human protein extracts; however, the mechanism by which it enters the proteome is still unclear. It has been suggested that BMAA is misincorporated at serine codons during protein synthesis, but direct evidence of its cotranslational incorporation is currently lacking. Here, using LC-MS–purified BMAA and several biochemical assays, we sought to determine whether any aminoacyl-tRNA synthetase (aaRS) utilizes BMAA as a substrate for aminoacylation. Despite BMAA's previously predicted misincorporation at serine …
Characterization Of Abin-1 In The Traumatically Injured Brain, Aaron Orellana, Alana C. Conti
Characterization Of Abin-1 In The Traumatically Injured Brain, Aaron Orellana, Alana C. Conti
Medical Student Research Symposium
Traumatic brain injury (TBI) is associated with chronic pain and persistent neuroinflammation. Opioids are often prescribed in order to relieve pain symptoms, but recent evidence suggests that their use negatively impacts the neuropathology of TBI leading to behavioral impairments and exacerbated neuroinflammation. The de-ubiquinating enzyme tumor necrosis factor alpha-induced protein (TNFAIP)3 or A20, inhibits the inflammatory signaling transcription factor nuclear factor (NF)-kB leading to attenuation of the inflammatory response. A20-binding inhibitor of nuclear factor kB (ABIN-1), which physically interacts with A20, also plays a role in the inhibition of NF-kB and is poorly researched in the central nervous system (CNS). …
A Pathogenic Ufsp2 Variant In An Autosomal Recessive Form Of Pediatric Neurodevelopmental Anomalies And Epilepsy, Min Ni, Bushra Afroze, Chao Xing, Chunxiao Pan, Yanqiu Shao, Ling Cai, Brandi L. Cantarel, Jimin Pei, Nick V. Grishin, Stacy Hewson
A Pathogenic Ufsp2 Variant In An Autosomal Recessive Form Of Pediatric Neurodevelopmental Anomalies And Epilepsy, Min Ni, Bushra Afroze, Chao Xing, Chunxiao Pan, Yanqiu Shao, Ling Cai, Brandi L. Cantarel, Jimin Pei, Nick V. Grishin, Stacy Hewson
Department of Paediatrics and Child Health
Purpose: Neurodevelopmental disabilities are common and genetically heterogeneous. We identified a homozygous variant in the gene encoding UFM1-specific peptidase 2 (UFSP2), which participates in the UFMylation pathway of protein modification. UFSP2 variants are implicated in autosomal dominant skeletal dysplasias, but not neurodevelopmental disorders. Homozygosity for the variant occurred in eight children from four South Asian families with neurodevelopmental delay and epilepsy. We describe the clinical consequences of this variant and its effect on UFMylation.
Methods: Exome sequencing was used to detect potentially pathogenic variants and identify shared regions of homozygosity. Immunoblotting assessed protein expression and post-translational modifications in patient-derived fibroblasts. …
Clinical Utility Of Molecular Profiling In Recurrent Glioblastoma Multiforme, Rebecca P. Bystrom, Pavalan Selvam, Jens Rueter, Honey Reddi, Christine Lu-Emerson
Clinical Utility Of Molecular Profiling In Recurrent Glioblastoma Multiforme, Rebecca P. Bystrom, Pavalan Selvam, Jens Rueter, Honey Reddi, Christine Lu-Emerson
Journal of Maine Medical Center
Introduction: Glioblastoma multiforme (GBM) is the most common and aggressive primary malignant brain tumor found in adults. GBM has limited therapeutic options. Initial tumor sampling establishes the histopathologic diagnosis, identifies prognostic and therapeutic biomarkers, and provides an opportunity for molecular profiling. By contrast, the utility of repeat tumor sampling and molecular profiling in recurrent GBM is not well established.
Clinical Findings: We present a 69-year-old woman with GBM whose tumor recurred after standard treatment with temozolomide (TMZ) and concurrent radiation, followed by adjuvant TMZ. This patient had a methylated O6-methylguanine-DNA methyltransferase (MGMT) promoter, which ordinarily predicts a favorable response to …
Open Neuroscience Initiative, Austin Lim
Open Neuroscience Initiative, Austin Lim
College of Science and Health Full Text Publications
The Open Neuroscience Initiative is a free-to-use textbook
This project began as a means to overcoming the financial burden that face undergraduate neuroscience students when buying textbooks. By compiling and writing a completely free-to-access textbook that covers the foundations of a typical college introduction to neuroscience course, students would have one less obstacle to overcome in their educational career, allowing them to focus their valuable time and attention on learning rather than finances. To make this project a reality, I began with a humble tweet in May 2019 that managed to gain a tiny bit of traction among the neuroscience …
Genus Applications For Alzheimer's Disease Pathology, Whitney L Carter
Genus Applications For Alzheimer's Disease Pathology, Whitney L Carter
Undergraduate Arts and Research Showcase
Estimates vary, but it is thought that 5.5 million Americans age 60 and up may be living with Alzheimer’s diseases (AD). AD is the most common type of dementia and is characterized by a decline in episodic memories, long-term memory, language, attention, and personality changes. The first symptoms can vary, but for most people memory is the first capacity to become impaired. However, symptoms can also be a decline in non-memory aspects of cognition like work-finding, vision/spatial issues, and impaired reasoning or judgement. AD is identified mainly by two histopathological features: extracellular plague of amyloid-beta protein and intracellular neuronal tangles …